Man Group plc Increases Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Man Group plc increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 217,782 shares of the company's stock after purchasing an additional 5,685 shares during the period. Man Group plc owned approximately 0.25% of HealthEquity worth $20,896,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Wealthfront Advisers LLC bought a new stake in shares of HealthEquity during the 4th quarter worth approximately $10,304,089,000. T. Rowe Price Investment Management Inc. acquired a new position in shares of HealthEquity during the fourth quarter worth $78,107,000. Norges Bank acquired a new stake in shares of HealthEquity during the 4th quarter valued at $74,701,000. Raymond James Financial Inc. acquired a new stake in shares of HealthEquity during the 4th quarter valued at $45,728,000. Finally, Iron Triangle Partners LP acquired a new position in HealthEquity in the 4th quarter worth about $32,202,000. 99.55% of the stock is currently owned by institutional investors.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now directly owns 84,969 shares of the company's stock, valued at $6,597,842.85. The trade was a 6.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HQY. The Goldman Sachs Group decreased their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price objective for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Wells Fargo & Company increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Barrington Research restated an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. Finally, KeyCorp decreased their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of $111.75.

HealthEquity Stock Down 2.3%

NASDAQ:HQY traded down $2.30 on Wednesday, hitting $98.88. The stock had a trading volume of 407,681 shares, compared to its average volume of 797,110. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The company has a market cap of $8.55 billion, a PE ratio of 90.72, a P/E/G ratio of 1.60 and a beta of 0.45. The business's fifty day moving average is $88.06 and its 200 day moving average is $97.23. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.